Jiangsu Sihuan Bioengineering Co Ltd Market Cap ($458.00 Million)
Market Cap & Net Worth: Jiangsu Sihuan Bioengineering Co Ltd (000518)
Jiangsu Sihuan Bioengineering Co Ltd market cap. Jiangsu Sihuan Bioengineering Co Ltd (SHE:000518) has a market capitalization of $458.00 Million (CN¥3.13 Billion) as of November 4, 2026. Listed on the SHE stock exchange, this China-based company holds position #12343 globally and #3544 in its home market, demonstrating a -9.25% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Jiangsu Sihuan Bioengineering Co Ltd's stock price CN¥3.04 by its total outstanding shares 1029556222 (1.03 Billion). Also see Jiangsu Sihuan Bioengineering Co Ltd (000518) cash conversion ratio for how efficiently the company converts equity into cash flow.
Jiangsu Sihuan Bioengineering Co Ltd Market Cap History (2015–2026)
Jiangsu Sihuan Bioengineering Co Ltd market cap history from 2015 to 2026. Data shows change from $1.07 Billion to $458.00 Million (-6.31% CAGR). Check current stock price of Jiangsu Sihuan Bioengineering Co Ltd for real-time trading data and today's change.
Jiangsu Sihuan Bioengineering Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Jiangsu Sihuan Bioengineering Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Jiangsu Sihuan Bioengineering Co Ltd equity growth rate to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.87x
Jiangsu Sihuan Bioengineering Co Ltd's market cap is 1.87 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.07 Billion | $237.84 Million | -$74.45 Million | 4.50x | N/A |
| 2016 | $1.34 Billion | $327.31 Million | $4.47 Million | 4.09x | 299.09x |
| 2017 | $1.03 Billion | $346.05 Million | $7.29 Million | 2.98x | 141.39x |
| 2018 | $521.27 Million | $395.51 Million | -$29.44 Million | 1.32x | N/A |
| 2019 | $546.88 Million | $417.88 Million | $14.33 Million | 1.31x | 38.16x |
| 2020 | $771.36 Million | $505.40 Million | $27.30 Million | 1.53x | 28.26x |
| 2021 | $546.88 Million | $350.96 Million | -$38.27 Million | 1.56x | N/A |
| 2022 | $477.58 Million | $270.15 Million | -$53.28 Million | 1.77x | N/A |
| 2023 | $500.18 Million | $235.42 Million | -$75.27 Million | 2.12x | N/A |
| 2024 | $381.16 Million | $203.52 Million | -$109.99 Million | 1.87x | N/A |
Competitor Companies of 000518 by Market Capitalization
Companies near Jiangsu Sihuan Bioengineering Co Ltd in the global market cap rankings as of November 4, 2026. Also see 000518 total assets for a full breakdown of the balance sheet.
Key companies related to Jiangsu Sihuan Bioengineering Co Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #368 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #414 globally with a market cap of $68.22 Billion USD ( AU$96.41 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #494 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $530.76 |
| #368 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $973.36 |
| #414 | CSL Ltd | AU:CSL | $68.22 Billion | AU$198.72 |
| #494 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $228.44 |
Market Capitalization of Jiangsu Sihuan Bioengineering Co Ltd (2015–2026)
Market capitalization of Jiangsu Sihuan Bioengineering Co Ltd from 2015 to today. Between 2015 and today, Jiangsu Sihuan Bioengineering Co Ltd's market cap moved from $1.07 Billion to $ 458.00 Million, with a yearly change of -6.31%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥458.00 Million | +26.14% |
| 2025 | CN¥363.08 Million | -4.74% |
| 2024 | CN¥381.16 Million | -23.80% |
| 2023 | CN¥500.18 Million | +4.73% |
| 2022 | CN¥477.58 Million | -12.67% |
| 2021 | CN¥546.88 Million | -29.10% |
| 2020 | CN¥771.36 Million | +41.05% |
| 2019 | CN¥546.88 Million | +4.91% |
| 2018 | CN¥521.27 Million | -49.42% |
| 2017 | CN¥1.03 Billion | -22.97% |
| 2016 | CN¥1.34 Billion | +25.07% |
| 2015 | CN¥1.07 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Jiangsu Sihuan Bioengineering Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $458.00 Million USD |
| MoneyControl | $458.00 Million USD |
| MarketWatch | $458.00 Million USD |
| marketcap.company | $458.00 Million USD |
| Reuters | $458.00 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Jiangsu Sihuan Bioengineering Co Ltd
Jiangsu Sihuan Bioengineering Co., Ltd. engages in the pharmaceutical business in China. It offers delusheng and xindelusheng, an anti-tumor biotherapeutic drug for the treatment of kidney cancer, malignant melanoma, and cancerous chest and abdominal mass. It also engages in breeding and sales of flowers and seedlings; and landscaping projects. Jiangsu Sihuan Bioengineering Co., Ltd. was founded … Read more